Prognosis
Biotech With iPad-Sized Gene Sequencer Gets Foresite-Led Funding
This article is for subscribers only.
GenapSys Inc., a gene-sequencing company that wants to put a compact sequencing device no bigger than a tablet computer into the hands of doctors, has raised another $90 million in funding.
The financing was led by San Francisco-based venture-capital firm Foresite Capital.